Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSage Group Regulatory News (SGE)

Share Price Information for Sage Group (SGE)

Share Price is delayed by 15 minutes
Get Live Data
870.00    -13.20 (-1.49%)
Bid:
871.80
Ask:
873.00
Spread: 1.20 (0.138%)
Market Cap: £7.84b
SGE Live PriceLast checked at - London Stock Exchange

Intraday Sage Group Share Chart

Directorate Change

16 Dec 2024 09:30

RNS Number : 2119Q
Sage Group PLC
16 December 2024
 

 

The Sage Group plc.

16 December 2024

Non-executive Director Appointment

The Sage Group plc. ("Sage") is pleased to announce the appointment of Lori Mitchell-Keller to its Board as a Non-executive Director with effect from 7 February 2025.

 

Lori is a global technology leader and strategic advisor who has over 30 years of experience of scaling, differentiating, and advancing businesses through technology transformation. She has held a number of global executive leadership roles at Google Cloud, SAP, JDA Software, Manugistics Software, and Allegiance Healthcare, and has built a strong track record of spearheading industry focussed product solutions and growth strategies.

 

Lori is a board member of XTANT Medical Holdings Inc, a NYSE listed company, and Mitratech Holdings Inc. She holds an MBA from the J.L. Kellogg Graduate School of Management at Northwestern University, a Master's degree in operations research from Stanford University, and a Bachelor's degree in industrial engineering from Iowa State University.

 

Andrew Duff, Chair, said "I am delighted to welcome Lori to the Sage Board. She brings a strong customer centric mindset, which she has used to inform product innovation and drive go-to-market strategy in some of the world's largest technology companies. Lori will strongly complement the existing Board capabilities and I look forward to the valuable contribution she will make in Board discussions as we continue to execute our strategy to deliver sustainable shareholder value."

 

There are no further disclosures required for the purposes of UKLR 6.4.6R and UKLR 6.4.8R.

Enquiries

Sage +44 (0) 7721 599 502

Vicki Bradin, General Counsel and Company Secretary

James Sandford, Investor RelationsDavid Ginivan, Corporate PRFGS Global +44 (0) 20 7251 3801

Conor McClafferty Sophia Johnston

About Sage

Sage exists to knock down barriers so everyone can thrive, starting with the millions of small and mid-sized businesses served by us, our partners and accountants. Customers trust our finance, HR and payroll software to make work and money flow. By digitising business processes and relationships with customers, suppliers, employees, banks and governments, our digital network connects SMBs, removing friction and delivering insights. Knocking down barriers also means we use our time, technology and experience to tackle digital inequality, economic inequality and the climate crisis.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAQKABDFBDKOBD
Date   Source Headline
29th May 20262:15 pmRNSTotal Voting Rights
28th May 20266:25 pmRNSTransaction in Own Shares
28th May 20263:15 pmRNSDirector/PDMR Shareholding
27th May 20266:25 pmRNSTransaction in Own Shares
27th May 202611:05 amRNSDirector/PDMR Shareholding
26th May 20266:25 pmRNSTransaction in Own Shares
22nd May 20266:25 pmRNSTransaction in Own Shares
22nd May 202611:00 amRNSDirector/PDMR Shareholding
21st May 20266:25 pmRNSTransaction in Own Shares
21st May 20267:00 amRNSResults for the six months to 31 March 2026
20th May 20266:25 pmRNSTransaction in Own Shares
18th May 20266:25 pmRNSTransaction in Own Shares
15th May 20266:25 pmRNSTransaction in Own Shares
14th May 20266:25 pmRNSTransaction in Own Shares
13th May 20266:25 pmRNSTransaction in Own Shares
12th May 20266:25 pmRNSTransaction in Own Shares
11th May 20266:25 pmRNSTransaction in Own Shares
8th May 20266:25 pmRNSTransaction in Own Shares
7th May 20266:25 pmRNSTransaction in Own Shares
6th May 20266:25 pmRNSTransaction in Own Shares
5th May 20266:25 pmRNSTransaction in Own Shares
1st May 20266:25 pmRNSTransaction in Own Shares
30th Apr 20266:25 pmRNSTransaction in Own Shares
30th Apr 20264:15 pmRNSTotal Voting Rights
29th Apr 20266:25 pmRNSTransaction in Own Shares
28th Apr 20266:25 pmRNSTransaction in Own Shares
27th Apr 20266:25 pmRNSTransaction in Own Shares
24th Apr 20266:25 pmRNSTransaction in Own Shares
23rd Apr 20266:25 pmRNSTransaction in Own Shares
22nd Apr 20266:25 pmRNSTransaction in Own Shares
21st Apr 20266:25 pmRNSTransaction in Own Shares
14th Apr 20266:25 pmRNSHolding(s) in Company
14th Apr 20266:25 pmRNSTransaction in Own Shares
13th Apr 20266:25 pmRNSTransaction in Own Shares
10th Apr 20266:25 pmRNSTransaction in Own Shares
9th Apr 20266:25 pmRNSTransaction in Own Shares
8th Apr 20266:25 pmRNSTransaction in Own Shares
31st Mar 20263:45 pmRNSTotal Voting Rights
19th Mar 20266:25 pmRNSTransaction in Own Shares
18th Mar 20266:25 pmRNSTransaction in Own Shares
17th Mar 20266:25 pmRNSTransaction in Own Shares
17th Mar 20266:00 pmRNSDirector/PDMR Shareholding
16th Mar 20266:25 pmRNSTransaction in Own Shares
13th Mar 20266:25 pmRNSTransaction in Own Shares
12th Mar 20266:25 pmRNSTransaction in Own Shares
11th Mar 20263:47 pmRNSHolding(s) in Company
11th Mar 20263:47 pmRNSHolding(s) in Company
10th Mar 20266:25 pmRNSTransaction in Own Shares
10th Mar 20264:36 pmRNSDirector/PDMR Shareholding
10th Mar 20264:36 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.